North Dakota Administrative Code
Title 20 - State Board of Dental Examiners
Article 20-02 - Dentists
Chapter 20-02-01 - General Requirements
Section 20-02-01-12 - Dental prescribers and use of the prescription drug monitoring program

1. Assess a patient's drug monitoring program data every twelve months during the patient's treatment with a controlled substance.

2. Review the patient's prescription drug monitoring program data if the patient requests early refills or demonstrates a pattern of taking more than the prescribed dosage.

3. Review the patient's prescription drug monitoring program data if there is a suspicion of or a known drug overuse, diversion, or abuse by the patient.

4. Document the assessment of the patient's prescription drug monitoring program data.

5. Discuss the risks and benefits of the use of controlled substances with the patient, the patient's parent if the patient is an unemancipated minor child, or the patient's legal guardian or health care surrogate, including the risk of tolerance and drug dependence.

6. Request and review prescription drug monitoring program data on the patient if the practitioner becomes aware that a patient is receiving controlled substances from multiple prescribers.

7. Request and review the patient's prescription drug monitoring program data if the prescriber has a reasonable belief that the patient may be seeking the controlled substance, in whole or in part, for any reason other than the treatment of an existing medical condition.